Successful Treatment of γ-Heavy-Chain Disease with Rituximab and Fludarabine

An 84-year-old Japanese man was admitted because of pancytopenia. The bone marrow was hypoplastic with a predominance of abnormal small lymphocytes and grape cells, which were positive for CD19 and CD20, and partially for the surface ĸ-light chain. Systemic CT scanning showed neither lymph node swel...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Acta haematologica 2012-01, Vol.128 (3), p.139-143
Hauptverfasser:	Inoue, Daichi, Matsushita, Akiko, Kiuchi, Mineyo, Takiuchi, Yoko, Nagano, Seiji, Arima, Hiroshi, Mori, Minako, Tabata, Sumie, Yamashiro, Akiko, Maruoka, Hayato, Oita, Tatsuo, Imai, Yukihiro, Takahashi, Takayuki
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged, 80 and over Antibodies, Monoclonal, Murine-Derived - therapeutic use Case Report Heavy Chain Disease Humans Lymphoma, B-Cell - drug therapy Male Rituximab Vidarabine - analogs & derivatives Vidarabine - therapeutic use Waldenstrom Macroglobulinemia - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!